Biohaven pharmaceuticals inaugural partner of national ataxia foundation's drug development collaborative

New haven, conn., nov. 11, 2020 /prnewswire/ -- biohaven pharmaceutical holding company ltd. (nyse: bhvn), a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and...
BHVN Ratings Summary
BHVN Quant Ranking